Skip to main content
Download PDF

Bone marrow mesenchymal stem cell-derived exosomes shuttle microRNAs to endometrial stromal fibroblasts that promote tissue proliferation /regeneration/ and inhibit differentiation

Stem Cell Research & Therapy volume 15, Article number: 129 (2024) Cite this article

Abstract

Background

Human bone marrow-derived stem cells (hBMDSCs) are well characterized mediators of tissue repair and regeneration. An increasing body of evidence indicates that these cells exert their therapeutic effects largely through their paracrine actions rather than clonal expansion and differentiation. Here we studied the role of microRNAs (miRNAs) present in extracellular vesicles (EVs) from hBMDSCs in tissue regeneration and cell differentiation targeting endometrial stromal fibroblasts (eSF).

Methods

Extracellular vesicles (EVs) are isolated from hBMDSCs, characterized by transmission electron microscopy (TEM) and nanoparticle tracking analysis (NTA) techniques. Extracted total RNA from EVs was subjected to RNA seq analysis. Transfection and decidualization studies were carried out in endometrial stromal fibroblasts (eSF). Gene expression was analyzed by qRTPCR. Unpaired t-test with Welch’s correction was used for data analysis between two groups.

Results

We identified several microRNAs (miRNAs) that were highly expressed, including miR-21-5p, miR-100-5p, miR-143-3p and let7. MiR-21 is associated with several signaling pathways involved in tissue regeneration, quiescence, cellular senescence, and fibrosis. Both miR-100-5p and miR-143-3p promoted cell proliferation. MiR-100-5p specifically promoted regenerative processes by upregulating TGF-ß3, VEGFA, MMP7, and HGF. MiR-100-5p blocked differentiation or decidualization as evidenced by morphologic changes and downregulation of decidualization mediators including HOXA10, IGFBP1, PRL, PR-B, and PR.

Conclusion

EVs delivered to tissues by hBMDSCs contain specific miRNAs that prevent terminal differentiation and drive repair and regeneration. Delivery of microRNAs is a novel treatment paradigm with the potential to replace BMDSCs in cell-free regenerative therapies.

Background

Regenerative capacity of organs and tissue is an essential biological process for the long-term survival of living organisms [1, 2]. In adults, tissue regeneration after injury usually leads to scar formation and abnormal tissue re-organization due to loss of regenerative capacity during development and aging [3, 4]. Few organs can fully regenerate without scarring [5]. The extent of this regenerative capacity varies considerably among different tissues, which possess distinct and inherent cellular turnover potential [5]. However, adult tissue turnover is essential for the maintenance of multicellular living organisms in order to preserve and restore their morphology and function or to respond to external injury and stress. Adult mesenchymal stem cells (MSCs) are pluripotent undifferentiated cells responsible for homeostasis as well as regeneration of specific mammalian tissues [6]. MSCs have a unique capacity for either symmetric or asymmetric division that allows for both self-renewal and the generation of mature functional cells in a cell-lineage-specific fashion [6]. Surprisingly, adult stem cells are rare, often quiescent, proliferate less and function in a paracrine manner in various physiological processes [7].

Bone marrow derived mesenchymal stem cells (BMDSCs) are a source of adult multipotent stem cells that can differentiate and influence multiple tissues due to their ability to travel to distant sites in response to factors released from target tissues [8]. They also secrete bioactive molecules that promote tissue regeneration as well as stimulate proliferation or differentiation of endogenous progenitors. The paradigm has shifted toward a bidirectional secretome-based paracrine activity, rather than cellular engraftment and differentiation as the principal action of MSCs. MSCs shuttle extracellular vesicles (EVs) that underly some of their physiological and pathological effects [9]. EVs have been detected in almost all human cells (including stem cells [10] and in multiple biofluids [11] - and have a role in both normal and pathological conditions [12]. EVs, particularly exosomes, are a heterogeneous spherical lipid bilayer membrane nanoparticles that constitute a refined system of cell-to-cell communication characterized by transfer of biomolecules (proteins, lipids, nucleic acids and metabolites) from donor to recipient cell where they can influence cell fate, function, and plasticity in the target tissue [13,14,15]. Exosomes are secreted by most cells in the body and are formed through a series of steps such as invagination of the plasma membrane, budding of intracellular organelle membranes, exocytosis of intraluminal vesicles [16, 17] into the extracellular matrix, or circulation. The secreted or released exosomes reach their target cells through the circulation and are then internalized by the recipient cells [2]. Then, the components of exosomes are released into the recipient cell cytoplasm, which results in the activation of intracellular signaling pathways that modulate cellular processes and functions. Exosomes from hBMDSCs may contain specific biological molecules, including microRNAs (miRNAs), which exert specific effects on recipient cells that mediate the therapeutic effects of hBMDSCs [18].

The endometrium, the mucosal inner layer of the uterus, is unique in regenerating its tissue. Endometrial regeneration is a highly coordinated, carefully controlled, hormonal-dependent process during a woman’s reproductive life. Previously, we reported the first evidence of bone marrow’s contribution to regeneration of both stromal and epithelial cells in the endometrium [19], which was confirmed in multiple subsequent studies [20, 21]. While stromal decidual differentiation is crucial for pregnancy [22], but sloughed during the menstrual cycle, parturition, or injury [23,24,25], the endometrium regenerates repetitively [26]. Moreover, recent studies suggest that BMDSC engraftment dramatically increases during pregnancy, where they are crucial for successful uterine angiogenesis and stromal decidual differentiation [27, 28]. However, the role and mechanism by which BMDSC remodel tissues is still poorly understood. Here we investigated the role of miRNAs from EVs derived from hBMDSCs and identified their role in the regulation of tissue regeneration using endometrial differentiation and repair in an in-vitro model.

Materials and methods

Extracellular vesicles (EVs) isolation from h-BMDSCs

Human bone marrow derived mesenchymal stem cells (hBMDSCs) were obtained from ATCC (American Type Culture Collection, Manassas, Virginia, USA). The cells were grown in T75 tissue culture flasks with mesenchymal stem cell basal medium (ATCC) with 10% fetal bovine serum, and 1% antibiotic-antimycotic. Cells were allowed to reach 70–80% confluence for 48 hr and then cells were maintained in serum free media for 24 hr before supernatant was collected. EVs were collected from the supernatants of h-BMDSCs according to the MISEV2018 guidelines. EVs were isolated and purified from the supernatants collected, using ExoQuick-TC® ULTRA kit (Systems Biosciences, Palo Alto, CA, USA) according to the manufacturer protocol. We also used ultracentrifugation method for the isolation of EVs. Both methods provided a similar yield (Supplemental Fig. 1).

Characterization of EVs

The nature of the isolated EVs was confirmed by Transmission Electron Microscopy (TEM). Briefly, EVs were mixed with 4% paraformaldehyde (Sigma Aldrich, St. Louis, MO, USA) for 30 min, counterstained with Alcian blue (Sigma Aldrich) for 30 min, washed with phosphate buffered saline (PBS) four times and centrifuged at 15,000 g for 5 min. EV pellets were fixed in 2% glutaraldehyde for 5 min. Resuspended EV mixtures were transferred to 300-mesh formvar nickel grids and incubated for 40 min. All grids were negatively stained with 4% saturated aqueous uranyl acetate for 15 min and then analyzed using an FEI Tecnai Osiris transmission electron microscope at 200 kV (FEI). All EVs detected were subjected to morphometric analysis and the exosome size and quantification were determined by nanoparticle tracking analysis (NTA) using ZetaView PMX 110 (Particle Metrix, Meerbusch, German). Data analysis was performed using ZetaView software (Particle Metrix, Meerbusch, German).

RNA-Seq

Total RNA was isolated from EVs by Qiagen RNeasy Plus Micro Kit, and RNA concentration was determined by NanoDrop 2000 (Thermo Fisher Scientific). RNA quality analysis, library preparation, and sequencing were performed by the Yale Center for Genomic Analysis. RNA was measured using an Agilent 2000 Bioanalyzer, which utilized the Agilent RNA 6000 Pico Chip (Agilent, Santa Clara, CA) per the manufacturer’s specifications. Illumina TrueSeq Library Preparation Kit (Illumina, San Diego, CA) was used for RNA-seq library preparation in accordance with the manufacturer’s protocol. Random primers were used for first-strand synthesis and then second-strand synthesis was performed with dUTP for generating strand-specific sequencing libraries. The parameters were set for single-end chemistry, high output, and 56-bp sequencing. Samples were multiplexed to six samples per lane. Libraries were sequenced on an Illumina HiSeq2500.

Transfection of eSFs with miRNAs

Human endometrial stromal cells23 (eSFs) were cultured in Dulbecco Modified Eagle Medium (DMEM) with high glucose, 10% fetal bovine serum (FBS), and 1% antibiotic-antimycotic (Life Technologies, Carlsbad, CA, USA) at 37 °C and 5% CO2. Cells were seeded into a twelve-well plate (4.0 × 104 cells/well). Transfection was carried out after 16 to 18 hr, at 30–40% confluence, with hsa-miR- 21-5p, hsa-miR-100-5p, hsa-miR-143-3p, hsa-let-7i-5p, hsa-let-7b-5p mimics or inhibitors (50 nM), or the respective negative controls (Bioneer Inc., Daejeon, South Korea) using the Lipofectamine RNAiMax transfection reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer’s protocol. After 72 hr, the cells were harvested, and the number of live cells was counted using a hemocytometer with the trypan blue staining method. Seventy-two hr after transfection, total RNA was isolated from cells and cDNA was prepared.

Induction of decidualization

To induce decidualization in vitro, both transfected and non-transfected eSFs were cultured in DMEM medium for 24 hr. Medium was replaced when cells reached to 70–80% confluence. The replaced medium containing 0.5 mM 8-Br-cAMP (Sigma-Aldrich) and 1 µM medroxyprogesterone acetate (MPA) (Sigma-Aldrich) was maintained for 7 days. The conditioned medium was collected and replaced every 24 hr and stored at -20 °C. Prolactin (PRL) protein levels were determined by using a commercially available ELISA kit (R&D Systems, Minneapolis, MN, US). eSFs were observed under an inverted microscope every 24 hr to study their morphological changes.

Quantitative real-time polymerase chain reaction (qRT-PCR)

Total RNA was isolated from transfected and non-transfected eSFs using RNeasy Plus Micro kit (Qiagen, cat. #74 − 34, Germantown, MA, USA). RNA (400 ng) was reverse transcribed to cDNA in a 20 µL reaction mixture using the iScript cDNA Synthesis Kit (Bio-Rad Laboratories). The specific primers used for each gene are shown in Table 1. As PR-A is truncated by 164 amino acids in the N-terminal regulatory domain, primers can only be designed for PR and PR-B (relative PR-A expression is calculated by PR minus PR-B expression). Gene expression was carried out by qRT-PCR using SYBR Green real-time PCR Master Mix (Bio-Rad Laboratories) to measure the mRNA levels of Ki67, HOXA10, IGFBP-1, PRL, PGR, PGR-B, VEGFA, TGFβ3, MMP7, HGF, GREM2, LTBP1, VEGFC, SCLC43A2, and IL6R. SYBR Green (Bio-Rad) was optimized in the MyiQ Single Color Real-Time PCR Detection System (Bio-Rad). qRT-PCR was carried out for 39 cycles of denaturation at 95◦C for 10 s, following activation at 95◦C for 3 min, and annealing at 60 °C for 30 s. The specificity of the amplified transcript and absence of primer-dimers was confirmed by a melting curve analysis. Gene expression was normalized to GAPDH as an internal control. Relative mRNA expression was calculated using the comparative cycle threshold method (CT), also known as 2−ΔΔCT method. Each sample was analyzed in triplicate, and all experiments were repeated at least three times. Nuclease-free water was used as a negative control replacing the cDNA template.

Table 1 Primer sequences used for qRTPCR
Full size table

Statistical analysis

GraphPad Prism version 9.4.1 (458) (San Diego, CA, USA) was used for statistical analysis. Student t-test was used to compare between two groups after determining homogeneity of variance. Data were represented as mean ± standard error of the mean (SEM). p < 0.05 was considered statistically significant.

Results

Characterization of EVs from hBMDSCs

EVs isolated and purified from the supernatants of hBMDSCs were characterized by transmission electron microscopy (TEM). TEM showed a typical cup-shaped morphology with a bilayer membrane and a diameter of approximately 100 nm (Fig. 1a). Additionally, nanoparticle tracking analysis (NTA) showed that the main peak and the median particle size was in the range of exosomes as shown in Fig. 1b (i) and (ii) respectively.

Fig. 1
figure 1

Characterization of extracellular vesicles (EVs). (a) Morphology of EVs showing a typical cup-shaped structure with a bilayer membrane and a diameter of approximately 100 nm, measured by transmission electron microscopy (TEM). (b i & ii) Shows the main peak and the median particle size respectively, in the range of exosomes determined by the nanoparticle tracking analysis (NTA)

Full size image

MiRNAs in exosomes from hBMDSCs

In order to know the presence and expression pattern of miRNAs in exosomes derived from hBMDSCs, we extracted exosomes from hBMDSCs using both ultracentrifugation and a commercial isolation kit utilizing RNA-seq focused specifically on small RNAs. Both methods showed similar pattern of miRNAs (Supplementary Fig. 1). RNA-seq data analysis identified a total of 2888 miRNAs. Of those 409 miRNAs were consistently expressed in multiple experiments. Among 409 miRNAs, the 25 most abundant are shown in Fig. 2. MiR-21-5p was found to be most abundant followed by miR-100-5p, miR-143-3p, miR-let-7i and miR-let-7b. We studied the first three miRs (miR-21, miR-100 and miR-143) for their role in tissue regeneration and differentiation.

Fig. 2
figure 2

Analysis of RNA-seq. RNA seq analysis showing the top 25 miRNAs that are highly expressed in extracellular vesicles from BMDSCs. MiR-21-5p is most highly expressed followed by miR-100-5p, miR-143-3p, miR-let-7i, and miR-let-7b, with a minimum of 5000 copies

Full size image

Effects of hsa-miR-21-5p on gene expression

RNA-seq data showed miR-21-5p to be the most abundant miRNA in hBMDSCs-derived EVs. To assess the effects of this miRNA on gene expression in tissue reprogramming, we transfected either miR-21-5p or its mimic negative control in eSFs. RNA sequencing was used to identify differentially expressed genes by using cut-offs of fold change > 1.2 or ≤ 0.83; P value < 0.05. We found that 66 genes are differentially expressed in eSFs transfected with miR-21-5p compared to the mimic negative control. Among these, 32 genes are upregulated while 34 are downregulated (Table 2). To determine the role of these genes in various physiological processes, we carried out Ingenuity Pathway Analyses (IPA). IPA results showed 14 genes to have roles in regeneration, cell cycle quiescence, cell differentiation, migration and/or angiogenesis. Among these 14 genes, 8 upregulated (CEMIP, BDKRB1, DDIT4, GREM2, ADM2, KRTAP1-5, VEGFC, and SCUBE3) and 6 downregulated (FAM47E-STBD1, NAP1L5, PPP1R3B, PLK2, ERRFI1 and CDC25A). We also analyzed these genes for their involvement in specific signaling pathways (Supplementary Fig. 2) that are involved in tissue regeneration, cellular senescence reversal, fibrosis attenuation, and stress response. Among the pathways identified by IPA analysis, the IL-17 signaling pathway is one that regulates inflammation, metabolism, fibrosis, and aging. The genes that are involved in the IL-17 signaling pathway were analyzed by qRT-PCR. Among them, GREM2 (p = 0.0009), LTBP1 (p = 0.048), VEGFC (p = 0.044) and SLC43A2 (p = 0.017) were significantly upregulated while IL6R (p < 0.0001), was downregulated significantly as shown in supplementary Fig. 3.

Fig. 3
figure 3

Increased cell proliferation by hsa-miR-100-5p and miR-143-3p. (a) Shows the significant increase in cell counts and (b) shows significant increase in Ki67 mRNA levels compared to mimic-negative control (CTL) for 72 hr. Each bar represents the data from six individual experiments, and each experiment was performed in duplicate. Data are shown as mean ± standard error (SEM) CTL vs. mimic (** p < 0.01, *p < 0.05)

Full size image
Table 2 Up- and down regulated genes in eSFs transfected with miR-21
Full size table

MiR-100-5p and miR-143-3p promoted endometrial proliferation

We tested the effect of miR-100-5p, miR-143-3p, miR-let-7i-5p, and let-7b-5p on cell proliferation and differentiation. Figure 3a & b showed a significant increase (p < 0.05) in cell proliferation by miR-100-5p and miR-143-3p as determined by cell count (2-fold). Additionally, qRT-PCR showed an increase in Ki67 mRNA expression levels (1.75-fold). Transfection of miR-21-5p, let-7i-5p and miR-let-7b-5p did not show any significant effect on cell proliferation of eSFs.

Fig. 4
figure 4

miR-100-5p upregulates regenerative markers in eSFs. Transfection of miR-100-5p in eSFs significantly increased the mRNA levels of regeneration markers (a) TGF-ß3, (b) VEGFA, (c) MMP7, and (d) HGF compared to controls. Each bar represents the data from four individual experiments, and each experiment was performed in triplicate. Data are shown as mean ± standard error (SEM) CTL vs. mimic (*p < 0.05), ***p < 0.001, **** p < 0.0001)

Full size image

MiR-100-5p induced regeneration of endometrial cells

To identify the role of miR-100-5p and miR-143-3p in tissue regeneration, we used eSFs for their regenerative potential. We found that transfection of eSFs with miR-100-5p significantly increased mRNA levels of TGFβ3, VEGFA, MMP7 and HGF (p < 0.05) as shown in Fig. 4. These results suggest that miR100-5p, which is highly expressed in EVs from h-BMDSCs, is likely to enhance the regenerative capacity of eSFs. We did not observe any effects on regeneration of endometrial cells by miR-143-3p.

Fig. 5
figure 5

Inhibition of decidualization by miR-100-5p and miR-143-5p. eSFs with and without transfection of miR-100-5p and miR-143-5p were treated with cAMP + MPA. Prolactin was estimated in conditioned medium by ELISA. (a) Shows significant increase in PRL levels after 7 days in normal cells treated with cAMP + MPA compared to no treatment. (b) Shows no significant increase in PRL levels in cells transfected with miRNAs compared to cells without transfection. Each bar represents the data from two individual experiments, and each experiment was performed in duplicate. Data are shown as mean ± standard error (SEM) CTL vs. Decidualization (*** p < 0.001)

Full size image

miR-100-5p inhibited differentiation/decidualization of eSFs

To know the function of miR-100-5p and miR-143-3p in cell differentiation/decidualization, we used an in-vitro model of decidualization where eSFs were treated with medroxy- progesterone in combination with cAMP. After 7 days, the prolactin (PRL) levels were measured from the conditioned media using ELISA. Prolactin levels were found to be significantly greater in non-transfected cells than in cells transfected with miR-100-5p and miR-143-3p (Fig. 5a & b).

Fig. 6
figure 6

Effect of miR-100-5p on decidualization markers. mRNA levels of decidualization markers were determined by qRT-PCR. (a) Shows the significant upregulation of mRNA levels of decidualization markers HOXA10, IGFBP-1, PRL, PR-B, and PR in normal eSFs treated with cAMP + MPA for 7 days (DEC), compared to control group (CTL). (b) Shows that miRNA miR-100-5p significantly downregulates mRNA levels of decidualization markers HOXA10, IGFBP-1, PRL, PR-B and PR significantly in eSFs compared to non-transfected cells with the mimic control. Each bar represents the data from four individual experiments, and each experiment was performed in triplicate. Data are shown as mean ± standard error (SEM) CTL vs. DEC and mimic negative control vs. miR-100-5p transfection. (*p < 0.05), **p < 0.01, ***p < 0.001)

Full size image

To determine the effect of miR-100-5p and miR-143-3p on decidualization, we induced decidualization in eSFs alone, eSFs transfected with miR-100-5p and miR-143-3p mimics, and the negative controls. Figure 6a shows a significant increase in mRNA levels of the decidualization markers HOXA10 (1.7-fold), IGFBP-1 (150-fold), PRL (7-fold), PR-B (5-fold), and PR (10-fold), in eSFs treated with cAMP + MPA. eSFs transfected with miR-100-5p mimic, significantly decreased mRNA levels of all decidualization markers (HOXA10 (2-fold), IGFBP-1 (6-fold), PRL (5-fold), PR-B (2.5-fold) and PR (8-fold) compared to controls (Fig. 6b). We did not observe any significant decrease in mRNA levels of these markers in eSFs transfected with miR-143-3p during induced decidualization, the morphological changes in cell structures were also recorded. eSFs transfected with the negative control became rounder with increased cell volume and ambiguous cell boundaries, which are typical features of decidual cells (Figs. 7b) compared to normal cells (Fig. 7a). These morphological changes were inhibited in cells transfected with either mir-100-5p or 143-3p as showed in Fig.  7 c & d respectively. These data suggest that miR-100-5p, block the endometrial cell differentiation, allowing for continued proliferation and tissue repair.

Fig. 7
figure 7

Inhibition of decidualization of eSFs in vitro by miR-100-5p and miR-143-3p. (a) Normal eSFs (HESCs), (b) eSFs transfected with miRNA mimic control. Cells gradually changed to typical decidual cells after 7 days of cAMP + MPA treatment. (c & d) eSFs transfected with miR-100-5p and miR-143-3p respectively. No typical or partial decidual changes were observed after 7 days treatment of cAMP + MPA

Full size image

Discussion

In this study, we described the role of the microRNAs miR-21-5p, miR-100-5p, miR-143-3p which are carried and transported by EVs (specifically exosomes) from hBMDSCs in tissue regeneration and decidualization using a eSF cell line in-vitro. Our results revealed that these miRNAs, which are highly abundant in hBMDSCs-derived exosomes, induce stromal cell proliferation and tissue regeneration while inhibiting the decidual differentiation of hormone-mediated stromal cells in the endometrium. Tissue regeneration requires a pause in the normal differentiation process to allow cell proliferation and repair. Specific miRNAs from EVs derived from hBMDSCs can influence the endometrial regenerative capacity and therefore participate in regeneration.

MSCs are crucial in the maintenance of tissue homeostasis and restoration after injury. MSCs were first isolated from mouse bone marrow [29] and are known to differentiate into several non-hematopoietic cells of visceral mesodermal, endodermal and ectodermal tissues [6, 8]. However, humans have a limited capacity to regenerate, and the extent of this regenerative capacity varies among different adult tissues. Each tissue has an inherently different cellular turnover and repair potential [1]. hBMDSCs were thought to maintain tissue homeostasis by serving as stem cell reservoirs for tissue repair and regeneration. Additionally, MSCs are thought to drive the fate of endogenous tissue-resident progenitor cells and to participate in adult cell plasticity [30, 31]. However, recent evidence suggests, that the principal action of BMDSCs is likely due to bidirectional intercellular paracrine communication [7, 10]. Low stem cell engraftment in target tissues is insufficient to justify their often-dramatic effects, supporting the idea that the final effectors of regenerative processes are likely to be paracrine soluble factors released by the stem cells.

Analysis of miR-21-5p data especially IPA analysis suggest that it mediates tissue regeneration, including stress response and inhibition of senescence and fibrosis. MiR-21 has been linked to the regulation of skin damage and wound re-epithelization through regulating angiogenic and inflammatory pathways [32]. Exosomal miR-21 derived from M2.

macrophages was recently found to promote angiogenesis and wound healing, leading to a successful regeneration of skin functional microstructure in-vivo [33]. Similarly, MiR-21-loaded and internalized exosomes have been associated with spinal cord injury repair [34], axonal regeneration [35], osteogenesis [36], liver regeneration, and lung regeneration [37]. We identified several mRNAs regulated by miR-21 that are likely to contribute to the regeneration of embryonic and adult tissues (including the endometrium) by promoting cell cycle quiescence, cell differentiation, migration, and/or angiogenesis [38,39,40,41,42]. Some have been also implicated in the reversal of cellular senescence [43,44,45], the attenuation of fibrosis [45, 46] and the stress response [47, 48]. Specifically, BDKRB1, a bradykinin G-coupled receptor B1, was significantly upregulated in eSFs by miR-21. A recent study, using transcriptomic analyses, revealed that its overexpression may contribute to the BMDSC trans-differentiation into the endometrial stromal lineage in the endometrium [49], reinforcing the idea that this microRNA may be affecting resident progenitor cells [50]. Similarly, we found that ERRFI1 was significantly downregulated by miR-21 in eSFs, consistent with its suppressive effects on endometrial cell proliferation [51]. Finally, upregulation of UCP2 was found to be essential for the prevention of induced oxidative stress in eSFs [52]. By IPA, we noted that IL-17 signaling was significantly activated in eSFs treated with miR-21, indicating that this immunomodulatory and metabolic pathway plays an essential role in tissue homeostasis and repair [53]. IL-17 signaling promotes cell proliferation and coordinate, tissue repair and wound healing in several tissues following injury or inflammation [54,55,56,57]. IL-17 signaling is pleiotropic, and outcomes are influenced by several signals present in the same environment, potentially contributing to IL-17-driven homeostasis, diseases, or aging [53, 55]. Given that this effect is likely context-dependent modulation of cytokine production by stem cells (rather than constitutive IL-17 signaling) may be advantageous in tissue repair.

Interestingly, we found that hsa-miR-100-5p promoted gene expression of four crucial angiogenic and reparative factors related to endometrial regeneration (TGFβ3, VEGFA, MMP-7 and HGF), thus reinforcing the reparative potential of miRNA-derived exosomes on eSFs. HGF is a pleiotropic factor which can promote the motility, migration, and proliferation of a wide spectrum of cells. HGF has been implicated in endometrial remodeling and cell proliferation during both the menstrual cycle (under estrogen influence) and via auto/paracrine mechanisms [58, 59]. VEGFA is increased at the time of endometrial repair and regeneration, mostly during the endometrial proliferative phase, both in humans [60] and primates [61]. Additionally, progesterone withdrawal is necessary for this pre and post-menstrual expression. MMPs are differentially expressed during the menstrual cycle, and therefore play a significant role in normal endometrial remodeling via degradation of the extracellular matrix. MMP-7 specifically is required for the reepithelization of mucosal wounds [62] and is highly expressed during the endometrial proliferative phase, exerting functions associated with tissue regeneration and angiogenesis [63,64,65]. Isoform 3 of TGFβ is also highly expressed during the proliferative phase [66] and has recently been identified as a potential regenerative anti-scarring therapy for skin [67]. Moreover, in the luteal phase, progesterone strongly inhibits both MMP-7 [68, 69] and TGFβ3 [70], consistent with the concept that differentiation and regeneration are distinct cellular processes that cannot occur simultaneously. Taken together, our data suggest that BMDSC-derived miRNAs promote proliferation and tissue repair remodeling.

Further, our study revealed that hsa-100-5p miRNA prevented the differentiation/ decidualization of eSFs by downregulating the HOXA10, IGFBP-1, PRL, PR-B, PR and genes which are the drivers of decidualization. This is consistent with the need to prevent differentiation in early endometrial regeneration/ repair. In a recent cross-sectional study, live birth rate was negatively associated with circulating miR-100-5p in women prior to beginning in vitro fertilization [71]. Similarly, miR-100-5p was found to be significantly upregulated in both plasma and decidual tissues during early pregnancy of women with recurrent miscarriage compared to controls [72]. Repair processes in the endometrium require that decidual differentiation is blocked to allow for proliferation, repair and regeneration. Thus, both processes may be reciprocally regulated by the same miRNAs. We did not observe any significant changes in the decidualization process for miR-143-3p.

The successful approval of MSC-based therapies has set the stage for regenerative medicine to become a common treatment modality for several degenerative diseases related to aging or abnormal/absent tissue regeneration [73, 74]. In particular, hBMDSCs have emerged as the most commonly used therapeutic cells because of their pleiotropic effects, intrinsic ability to migrate and engraft into target tissues, their renewal, and multipotent differentiation potential. They also provide a strong paracrine support for several physiological or pathological conditions [75, 76].

Taken together, our results suggests that hBMDSCs have a powerful and multifaceted paracrine effect on endometrial homeostasis by shuttling specific miRNAs via exosomes. These exosomal microRNAs have the ability to enhance the proliferative/regenerative potential and simultaneously prevent terminal differentiation, thus allowing for tissue proliferation and repair. Limitations of direct MSC-based therapy are post-administration cell loss, safety, and variability in therapeutic response. MSC-derived EVs are attractive candidates for cell-free therapies in regenerative medicine as they have shown stability in the extracellular biofluids, excellent biocompatibility, and low toxicity and immunogenicity [77]. Moreover, EVs can cross the blood-brain barrier, allowing them to be a feature considered superior to the traditional MSC-based therapies.

Conclusions

We identified the major microRNAs present in EVs secreted by hBMDSCs, and demonstrated that the miRNAs miR-21-5p, miR-100-5p, and miR-143-3p are involved in regulating the genes responsible for endometrial regeneration and decidualization. To determine whether the hBMDSCs-derived microRNAs can be used as therapeutic agents, in-vivo studies are needed to confirm our in-vitro studies. These studies will help in replace stem-cell-based cellular therapies with cell free treatments using biomolecules such as microRNAs, thus serving as new therapeutics for tissue regeneration and repair.

Data availability

Data available with Ramanaiah Mamillapalli and Hugh Taylor.

Abbreviations

miRNAs:

microRNAs

h-BMDSCs:

human bone marrow-derived stem cells

EVs:

extracellular vesicles

TEM:

transmission electron microscopy

NTA:

nanoparticle tracking analysis

eSFs:

human endometrial stromal cells

MSCs:

mesenchymal stem cells

qRT-PCR:

quantitative real-time polymerase chain reaction

TGFβ3:

transforming growth factor-beta3

VEGFA:

vascular endothelial growth factor A

MMP7:

matrix metalloproteinase-7

HGF:

hepatocyte growth factor

HOXA10:

homeobox A10

IGFBP-1:

insulin-like growth factor-binding protein 1

PRL:

prolactin

PR-B:

progesterone-B

IPA:

ingenuity pathway analysis

References

  1. Rando TA. Stem cells, ageing and the quest for immortality. Nature. 2006;441(7097):1080–6.

    Article  CAS  PubMed  Google Scholar 

  2. Colombo M, Raposo G, Théry C. Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu Rev Cell Dev Biol. 2014;30:255–89.

    Article  CAS  PubMed  Google Scholar 

  3. Blais M, et al. Concise review: tissue-engineered skin and nerve regeneration in burn treatment. Stem Cells Transl Med. 2013;2(7):545–51.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Cui CY, Ferrucci L, Gorospe M. Macrophage involvement in Aging-Associated skeletal muscle regeneration. Cells, 2023. 12(9).

  5. Lindsey ML, Becirovic-Agic M. Skin wound healing as a mirror to cardiac wound healing. Exp Physiol; 2023.

  6. Pittenger MF, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284(5411):143–7.

    Article  CAS  PubMed  Google Scholar 

  7. Baraniak PR, McDevitt TC. Stem cell paracrine actions and tissue regeneration. Regen Med. 2010;5(1):121–43.

    Article  PubMed  Google Scholar 

  8. Jiang Y, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature. 2002;418(6893):41–9.

    Article  CAS  PubMed  Google Scholar 

  9. Kou M, et al. Mesenchymal stem cell-derived extracellular vesicles for immunomodulation and regeneration: a next generation therapeutic tool? Cell Death Dis. 2022;13(7):580.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Asgarpour K, et al. Exosomal microRNAs derived from mesenchymal stem cells: cell-to-cell messages. Cell Commun Signal. 2020;18(1):149.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Théry C et al. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol, 2006. Chapter 3: p. Unit 3.22.

  12. De Toro J, et al. Emerging roles of exosomes in normal and pathological conditions: new insights for diagnosis and therapeutic applications. Front Immunol. 2015;6:203.

    PubMed  PubMed Central  Google Scholar 

  13. Valadi H, et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007;9(6):654–9.

    Article  CAS  PubMed  Google Scholar 

  14. Bang C, Thum T. Exosomes: new players in cell-cell communication. Int J Biochem Cell Biol. 2012;44(11):2060–4.

    Article  CAS  PubMed  Google Scholar 

  15. Jeppesen DK, et al. Reassessment of Exosome Composition. Cell. 2019;177(2):428–e44518.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Riazifar M, et al. Stem cell Extracellular vesicles: extended messages of regeneration. Annu Rev Pharmacol Toxicol. 2017;57:125–54.

    Article  CAS  PubMed  Google Scholar 

  17. Tkach M, Théry C. Communication by Extracellular vesicles: where we are and where we need to go. Cell. 2016;164(6):1226–32.

    Article  CAS  PubMed  Google Scholar 

  18. Huang X, et al. Characterization of human plasma-derived exosomal RNAs by deep sequencing. BMC Genomics. 2013;14:319.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Taylor HS. ENdometrial cells derived from donor stem cells in bone marrow transplant recipients. JAMA. 2004;292(1):81–5.

    Article  CAS  PubMed  Google Scholar 

  20. Mints M, et al. Endometrial endothelial cells are derived from donor stem cells in a bone marrow transplant recipient. Hum Reprod. 2008;23(1):139–43.

    Article  CAS  PubMed  Google Scholar 

  21. Ikoma T, et al. Bone marrow-derived cells from male donors can compose endometrial glands in female transplant recipients. Am J Obstet Gynecol. 2009;201(6):e6081–8.

    Article  Google Scholar 

  22. Gellersen B, Brosens JJ. Cyclic decidualization of the human endometrium in reproductive health and failure. Endocr Rev. 2014;35(6):851–905.

    Article  CAS  PubMed  Google Scholar 

  23. Tal R, et al. Bone marrow-derived progenitor cells contribute to remodeling of the postpartum uterus. Stem Cells. 2021;39(11):1489–505.

    Article  CAS  PubMed  Google Scholar 

  24. Ulrich D, et al. Mesenchymal stem/stromal cells in post-menopausal endometrium. Hum Reprod. 2014;29(9):1895–905.

    Article  CAS  PubMed  Google Scholar 

  25. Paulson RJ, et al. Pregnancy in the sixth decade of life: obstetric outcomes in women of advanced reproductive age. JAMA. 2002;288(18):2320–3.

    Article  PubMed  Google Scholar 

  26. Bulletti C, et al. Early human pregnancy in vitro utilizing an artificially perfused uterus. Fertil Steril. 1988;49(6):991–6.

    Article  CAS  PubMed  Google Scholar 

  27. Tal R, et al. Adult bone marrow progenitors become decidual cells and contribute to embryo implantation and pregnancy. PLoS Biol. 2019;17(9):e3000421.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Tal R, et al. Bone-marrow-derived endothelial progenitor cells contribute to vasculogenesis of pregnant mouse uterus†. Biol Reprod. 2019;100(5):1228–37.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Friedenstein AJ, Gorskaja JF, Kulagina NN. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol. 1976;4(5):267–74.

    CAS  PubMed  Google Scholar 

  30. Raff M. Adult stem cell plasticity: fact or artifact? Annu Rev Cell Dev Biol. 2003;19:1–22.

    Article  CAS  PubMed  Google Scholar 

  31. Jopling C, Boue S, Izpisua Belmonte JC. Dedifferentiation, transdifferentiation and reprogramming: three routes to regeneration. Nat Rev Mol Cell Biol. 2011;12(2):79–89.

    Article  CAS  PubMed  Google Scholar 

  32. Xie J, et al. Roles of MicroRNA-21 in skin Wound Healing: a Comprehensive Review. Front Pharmacol. 2022;13:828627.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Lyu L, et al. Exosomes derived from M2 macrophages induce angiogenesis to promote wound healing. Front Mol Biosci. 2022;9:1008802.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Zhang T, et al. The protective effect of microRNA-21 in neurons after spinal cord injury. Spinal Cord. 2019;57(2):141–9.

    Article  PubMed  Google Scholar 

  35. Ma Y, et al. Human umbilical cord mesenchymal stem cell-derived extracellular vesicles promote the proliferation of Schwann Cells by regulating the PI3K/AKT signaling pathway via transferring miR-21. Stem Cells Int. 2021;2021:p1496101.

    Article  Google Scholar 

  36. Kurita T, Li X, Bhawal UK. Crosstalk between microRNA-21-5p and the transcription factor Dec1 maintains osteoblast function. Biochem Biophys Res Commun. 2022;632:32–9.

    Article  CAS  PubMed  Google Scholar 

  37. Yan-nan B, et al. MicroRNA-21 accelerates hepatocyte proliferation in vitro via PI3K/Akt signaling by targeting PTEN. Biochem Biophys Res Commun. 2014;443(3):802–7.

    Article  PubMed  Google Scholar 

  38. Tanwar V, et al. Gremlin 2 promotes differentiation of embryonic stem cells to atrial fate by activation of the JNK signaling pathway. Stem Cells. 2014;32(7):1774–88.

    Article  CAS  PubMed  Google Scholar 

  39. Sarkar S, Dey BK, Dutta A. MiR-322/424 and– 503 are induced during muscle differentiation and promote cell cycle quiescence and differentiation by down-regulation of Cdc25A. Mol Biol Cell. 2010;21(13):2138–49.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Li W, et al. Gremlin2 regulates the differentiation and function of Cardiac Progenitor cells via the Notch Signaling Pathway. Cell Physiol Biochem. 2018;47(2):579–89.

    Article  CAS  PubMed  Google Scholar 

  41. Li L, et al. Knockdown of nucleosome assembly protein 1-like 1 promotes dimethyl sulfoxide-induced differentiation of P19CL6 cells into cardiomyocytes. J Cell Biochem. 2012;113(12):3788–96.

    Article  CAS  PubMed  Google Scholar 

  42. Wang F, et al. Accelerated bone regeneration by Adrenomedullin 2 through improving the Coupling of Osteogenesis and Angiogenesis via β-Catenin signaling. Front Cell Dev Biol. 2021;9:649277.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Magariños M, et al. Otic neurogenesis is regulated by TGFβ in a senescence-independent manner. Front Cell Neurosci. 2020;14:217.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Milewska M, Kolch W. Mig-6 participates in the regulation of cell senescence and retinoblastoma protein phosphorylation. Cell Signal. 2014;26(9):1870–7.

    Article  CAS  PubMed  Google Scholar 

  45. Qiao X, et al. Intermedin attenuates renal fibrosis by induction of heme oxygenase-1 in rats with unilateral ureteral obstruction. BMC Nephrol. 2017;18(1):232.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Gonzalez D, et al. ALS skeletal muscle shows enhanced TGF-β signaling, fibrosis and induction of fibro/adipogenic progenitor markers. PLoS ONE. 2017;12(5):e0177649.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Hu X, et al. Rh-CSF1 attenuates oxidative stress and neuronal apoptosis via the CSF1R/PLCG2/PKA/UCP2 signaling pathway in a rat model of neonatal HIE. Oxid Med Cell Longev. 2020;2020:p6801587.

    Article  Google Scholar 

  48. Kovaleva IE, et al. Intermedin/adrenomedullin 2 is a stress-inducible gene controlled by activating transcription factor 4. Gene. 2016;590(1):177–85.

    Article  CAS  PubMed  Google Scholar 

  49. Aghajanova L, et al. The bone marrow-derived human mesenchymal stem cell: potential progenitor of the endometrial stromal fibroblast. Biol Reprod. 2010;82(6):1076–87.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Mamillapalli R, Mutlu L, Taylor HS. Characterization of bone marrow Progenitor Cell Uterine Engraftment and Transdifferentiation. Reprod Sci. 2022;29(8):2382–90.

    Article  CAS  PubMed  Google Scholar 

  51. Jeong JW, et al. Mig-6 modulates uterine steroid hormone responsiveness and exhibits altered expression in endometrial disease. Proc Natl Acad Sci U S A. 2009;106(21):8677–82.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Lu X, et al. Zinc is essential for the transcription function of the PGC-1α/Nrf2 signaling pathway in human primary endometrial stromal cells. Am J Physiol Cell Physiol. 2020;318(3):C640–8.

    Article  PubMed  Google Scholar 

  53. Bechara R, McGeachy MJ, Gaffen SL. The metabolism-modulating activity of IL-17 signaling in health and disease. J Exp Med, 2021. 218(5).

  54. Song X, et al. Growth factor FGF2 cooperates with Interleukin-17 to repair intestinal epithelial damage. Immunity. 2015;43(3):488–501.

    Article  CAS  PubMed  Google Scholar 

  55. Chen X, et al. IL-17R-EGFR axis links wound healing to tumorigenesis in Lrig1(+) stem cells. J Exp Med. 2019;216(1):195–214.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. O’Connor W Jr., et al. A protective function for interleukin 17A in T cell-mediated intestinal inflammation. Nat Immunol. 2009;10(6):603–9.

    Article  PubMed  PubMed Central  Google Scholar 

  57. Huang H, et al. IL-17 stimulates the proliferation and differentiation of human mesenchymal stem cells: implications for bone remodeling. Cell Death Differ. 2009;16(10):1332–43.

    Article  CAS  PubMed  Google Scholar 

  58. Zhang X. Hepatocyte growth factor system in the mouse uterus: variation across the estrous cycle and regulation by 17-beta-estradiol and progesterone. Biol Reprod. 2010;82(6):1037–48.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Yoshida S, et al. Hepatocyte growth factor/Met system promotes endometrial and endometriotic stromal cell invasion via autocrine and paracrine pathways. J Clin Endocrinol Metab. 2004;89(2):823–32.

    Article  CAS  PubMed  Google Scholar 

  60. Maybin JA, et al. The regulation of vascular endothelial growth factor by hypoxia and prostaglandin F2α during human endometrial repair. J Clin Endocrinol Metab. 2011;96(8):2475–83.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  61. Nayak NR, Brenner RM. Vascular proliferation and vascular endothelial growth factor expression in the rhesus macaque endometrium. J Clin Endocrinol Metab. 2002;87(4):1845–55.

    Article  CAS  PubMed  Google Scholar 

  62. Caley MP, Martins VL, O’Toole EA. Metalloproteinases and Wound Healing. Adv Wound Care (New Rochelle). 2015;4(4):225–34.

    Article  PubMed  Google Scholar 

  63. Rodgers WH, et al. Expression and localization of matrilysin, a matrix metalloproteinase, in human endometrium during the reproductive cycle. Am J Obstet Gynecol. 1993;168(1 Pt 1):253–60.

    Article  CAS  PubMed  Google Scholar 

  64. Goffin F, et al. Expression pattern of metalloproteinases and tissue inhibitors of matrix-metalloproteinases in cycling human endometrium. Biol Reprod. 2003;69(3):976–84.

    Article  CAS  PubMed  Google Scholar 

  65. Aghajanova L, et al. In vitro evidence that platelet-rich plasma stimulates cellular processes involved in endometrial regeneration. J Assist Reprod Genet. 2018;35(5):757–70.

    Article  PubMed  PubMed Central  Google Scholar 

  66. Omwandho CO, et al. Role of TGF-betas in normal human endometrium and endometriosis. Hum Reprod. 2010;25(1):101–9.

    Article  CAS  PubMed  Google Scholar 

  67. Ferguson MW, et al. Prophylactic administration of avotermin for improvement of skin scarring: three double-blind, placebo-controlled, phase I/II studies. Lancet. 2009;373(9671):1264–74.

    Article  CAS  PubMed  Google Scholar 

  68. Bruner KL, et al. Transforming growth factor beta mediates the progesterone suppression of an epithelial metalloproteinase by adjacent stroma in the human endometrium. Proc Natl Acad Sci U S A. 1995;92(16):7362–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  69. Bruner KL, et al. Progesterone and transforming growth factor-beta coordinately regulate suppression of endometrial matrix metalloproteinases in a model of experimental endometriosis. Steroids. 1999;64(9):648–53.

    Article  CAS  PubMed  Google Scholar 

  70. Arici A, MacDonald PC, Casey ML. Modulation of the levels of transforming growth factor beta messenger ribonucleic acids in human endometrial stromal cells. Biol Reprod. 1996;54(2):463–9.

    Article  CAS  PubMed  Google Scholar 

  71. Butler AE, et al. Association of microRNAs with embryo development and fertilization in women undergoing subfertility treatments: a pilot study. Front Reprod Health. 2021;3:719326.

    Article  PubMed  PubMed Central  Google Scholar 

  72. Yang Q, et al. Association of the peripheral blood levels of circulating microRNAs with both recurrent miscarriage and the outcomes of embryo transfer in an in vitro fertilization process. J Transl Med. 2018;16(1):186.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  73. Yin JQ, Zhu J, Ankrum JA. Manufacturing of primed mesenchymal stromal cells for therapy. Nat Biomed Eng. 2019;3(2):90–104.

    Article  CAS  PubMed  Google Scholar 

  74. Ancans J. Cell therapy medicinal product regulatory framework in Europe and its application for MSC-based therapy development. Front Immunol. 2012;3:253.

    Article  PubMed  PubMed Central  Google Scholar 

  75. Chen P, et al. Endometriosis Cell Proliferation Induced by Bone Marrow Mesenchymal Stem cells. Reprod Sci. 2021;28(2):426–34.

    Article  CAS  PubMed  Google Scholar 

  76. Wang X, et al. Chemoattraction of bone marrow-derived stem cells towards human endometrial stromal cells is mediated by estradiol regulated CXCL12 and CXCR4 expression. Stem Cell Res. 2015;15(1):14–22.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  77. Shi J, et al. Mesenchymal stem cell-derived small extracellular vesicles in the treatment of human diseases: Progress and prospect. World J Stem Cells. 2021;13(1):49–63.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

NIH for financial support for research in reproductive sciences. Grant number NIH R01 HD076422. Grant awarded to Dr. Hugh S Taylor.

Author information

Author notes

  1. Giulia Bonavina

    Present address: IRCCS San Raffaele Scientific Institute, Milan, Italy

  2. Giulia Bonavina and Ramanaiah Mamillapalli contributed equally to this work.

Authors and Affiliations

  1. Department of Obstetrics, Gynecology and Reproductive Sciences, Yale School of Medicine, 310 Cedar Street, 06510, New Haven, CT, USA

    Giulia Bonavina, Ramanaiah Mamillapalli, Graciela Krikun, Yuping Zhou, Nimisha Gawde & Hugh S. Taylor

Authors
  1. Giulia Bonavina
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ramanaiah Mamillapalli
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Graciela Krikun
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yuping Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Nimisha Gawde
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hugh S. Taylor
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

GB: Carried out experiments, Data analysis, initial manuscript writing; RM: Data analysis, Preparation of figures, manuscript writing and editing; GK: Conception; YZ: EVs isolation; NG: Transfection studies; HT: Conception and design, edits and final approval.

Corresponding author

Correspondence to Ramanaiah Mamillapalli.

Ethics declarations

Ethics approval and consent to participate

Stem cells and endometrial regeneration, Yale University Institutional Animal Care and Use Committee (IACUC), Approval #2020–07113, August 28th, 2020.

Consent for publication

All authors and Institute given consent to publish the research data.

Competing interests

All authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Material 1

Supplementary Material 2

Supplementary Material 3

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bonavina, G., Mamillapalli, R., Krikun, G. et al. Bone marrow mesenchymal stem cell-derived exosomes shuttle microRNAs to endometrial stromal fibroblasts that promote tissue proliferation /regeneration/ and inhibit differentiation. Stem Cell Res Ther 15, 129 (2024). https://doi.org/10.1186/s13287-024-03716-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13287-024-03716-1

Keywords

Stem Cell Research & Therapy

ISSN: 1757-6512